Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson cEO to median-paid employee pay ratio (X:1)
DEF 14A Proxy Statement (CEO Pay Ratio Disclosure)
Latest, FY2025
360.00
Period ended Dec 28, 2025
Change on a year earlier
+22.9%
293.00 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CEO to median-paid employee pay ratio (X:1) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 360.00 | +22.9% | Proxy Statement (DEF 14A) (jnj-20260309.htm, filed 2026-03-11) ↗ |
| FY2024 | Dec 29, 2024 | 293.00 | -13.3% | Proxy Statement (DEF 14A) (jnj-20250311.htm, filed 2025-03-12) ↗ |
| FY2023 | Dec 31, 2023 | 338.00 | +106.1% | Proxy Statement (DEF 14A) (jnj-20240311.htm, filed 2024-03-13) ↗ |
| FY2022 | Jan 1, 2023 | 164.00 | -44.8% | Proxy Statement (DEF 14A) (jnj-20230313.htm, filed 2023-03-15) ↗ |
| FY2021 | Jan 2, 2022 | 297.00 | -18.6% | Proxy Statement (DEF 14A) (a2022jnjproxy.htm, filed 2022-03-16) ↗ |
| FY2020 | Jan 3, 2021 | 365.00 | +9.3% | Proxy Statement (DEF 14A) (jnjproxy2021.htm, filed 2021-03-10) ↗ |
| FY2019 | Dec 29, 2019 | 334.00 | – | Proxy Statement (DEF 14A) (jnjproxy2020.htm, filed 2020-03-11) ↗ |
Breakdown
What makes up ceo to median-paid employee pay ratio (x:1)
Cite this data
StockData. (2026). Johnson & Johnson CEO to median-paid employee pay ratio (X:1), annual FY2019–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ceo_pay_ratio
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.